Results 241 to 250 of about 18,324 (292)
Efficacy and safety of mycophenolate mofetil versus cyclophosphamide therapy for Henoch schonlein purpura nephritis in children: A meta-analysis. [PDF]
Medicine (Baltimore)Wang D, Liu T, Lu J, Li X, Liu X, Xu W.
europepmc +1 more source
Common Seasonal Pathogens and Epidemiology of Henoch-Schönlein Purpura Among Children.
JAMA Netw OpenFelix A +10 more
europepmc +1 more source
An Investigation of the Relationship between Henoch-Schönlein Purpura and Viral Infection in Korea Using the Health Insurance Database. [PDF]
J Clin MedPark SH, Jo SM, Kim SW, Lee JM, Baek HS.
europepmc +1 more source
Purpura and arthritis: Is it always Henoch-Schonlein purpura?
, 2016 Pradillo Martin, Maria Cristina +3 more
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Henoch‐Schönlein purpura: Another COVID‐19 complication
Pediatric dermatology, 2021Whether affecting children or adults, SARS‐CoV‐2 infection (COVID‐19) can have multi‐organ involvement mediated by an inflammatory cascade. Immunoglobulin A (IgA) is one of the key components of the inflammatory cascade that can lead to endothelial ...
G. El Hasbani +3 more
semanticscholar +1 more source
International journal of urology, 2021
Henoch–Schönlein purpura nephritis has become a significant threat to children's health. Traditional combined therapy of glucocorticoids and cyclophosphamide leads to severe toxicity and complications.
Huiwu Zhang +4 more
semanticscholar +1 more source
Henoch–Schönlein purpura nephritis has become a significant threat to children's health. Traditional combined therapy of glucocorticoids and cyclophosphamide leads to severe toxicity and complications.
Huiwu Zhang +4 more
semanticscholar +1 more source
Henoch-Schönlein Purpura in Children: An Updated Review.
Current pediatric reviews, 2020BACKGROUND Henoch-Schönlein purpura (HSP) is an IgA-mediated systemic small-vessel vasculitis with a predilection for the skin, gastrointestinal tract, joints, and kidneys. It is the most common form of systemic vasculitis in children.
A. Leung, B. Barankin, K. Leong
semanticscholar +1 more source
Archives of Disease in Childhood - Education and Practice, 2008
Henoch–Schonlein purpura (HSP) is the commonest vasculitis of childhood. The first description of this disorder was probably that of a young boy with “bloody points” over the shins of his legs, abdominal pain, blood in the stools and urine and painful subcutaneous oedema, described by William Heberden in 1801.
E J Tizard, M J J Hamilton-Ayres
openaire +3 more sources
Henoch–Schonlein purpura (HSP) is the commonest vasculitis of childhood. The first description of this disorder was probably that of a young boy with “bloody points” over the shins of his legs, abdominal pain, blood in the stools and urine and painful subcutaneous oedema, described by William Heberden in 1801.
E J Tizard, M J J Hamilton-Ayres
openaire +3 more sources
Endothelin levels in Henoch-Schonlein purpura [PDF]
Pediatric Nephrology, 2002 Henoch-Schonlein purpura (HSP) is one of the most common types of vasculitis disorders seen in childhood and is characterized by a rash, arthritis, abdominal pain, and renal involvement. Although HSP is an immunoglobulin A (IgA) related immune complex disease, the pathogenesis has not been fully elucidated.
Ismail Islek +7 more
openaire +3 more sources